Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment
LEQSELVI delivered statistically significant efficacy across two Phase 3 clinical trials
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
autoimmune disease
Roche bid to recycle Gayzva for lupus nephritis wins FDA breakthrough tag
There are no FDA-approved medicines for lupus nephritis, a life-threatening symptom of the autoimmune disease lupus in which the…